Handelen Merck & Co Inc - USD - MRK CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.19 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.030779% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.013666% | ||||||||
| Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Merck & Co Inc ESG Risk Ratings
High Medium Low Negligible
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Belangrijkste statistieken
| Prev. Close* | 102.83 |
| Open* | 102.87 |
| 1-Jaarlijkse Verandering* | 30.5% |
| Dagelijks bereik* | 102.87 - 104.38 |
| 52 wekelijks bereik | 72.88-115.49 |
| Weekgemiddelde volume (10 dagen) | 9.20M |
| Gemiddeld volume (3 maanden) | 186.82M |
| Marktkapitalisatie | 260.99B |
| P/E Ratio | 18.02 |
| Uitstaande Aandelen | 2.54B |
| Omzet | 59.28B |
| EPS | 5.71 |
| Dividend (opbrengst %) | 2.8366 |
| Beta | 0.35 |
| Volgende inkomsten datum | Apr 27, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 102.83 | 0.86 | 0.84% | 101.97 | 103.69 | 101.90 |
| Feb 2, 2023 | 103.24 | -0.28 | -0.27% | 103.52 | 105.70 | 101.59 |
| Feb 1, 2023 | 106.84 | 1.04 | 0.98% | 105.80 | 107.33 | 105.80 |
| Jan 31, 2023 | 107.31 | 1.22 | 1.15% | 106.09 | 107.34 | 105.73 |
| Jan 30, 2023 | 106.01 | 0.69 | 0.66% | 105.32 | 106.40 | 105.01 |
| Jan 27, 2023 | 105.29 | -0.40 | -0.38% | 105.69 | 106.48 | 105.01 |
| Jan 26, 2023 | 106.73 | -1.43 | -1.32% | 108.16 | 108.30 | 105.71 |
| Jan 25, 2023 | 108.49 | 1.14 | 1.06% | 107.35 | 109.83 | 107.35 |
| Jan 24, 2023 | 108.43 | -0.64 | -0.59% | 109.07 | 109.58 | 107.00 |
| Jan 23, 2023 | 109.70 | -0.03 | -0.03% | 109.73 | 110.26 | 109.06 |
| Jan 20, 2023 | 109.82 | 0.98 | 0.90% | 108.84 | 109.89 | 108.48 |
| Jan 19, 2023 | 109.77 | 2.03 | 1.88% | 107.74 | 110.08 | 107.74 |
| Jan 18, 2023 | 108.72 | -1.11 | -1.01% | 109.83 | 110.01 | 108.48 |
| Jan 17, 2023 | 110.35 | -1.51 | -1.35% | 111.86 | 112.38 | 110.22 |
| Jan 13, 2023 | 112.09 | 1.72 | 1.56% | 110.37 | 112.34 | 110.00 |
| Jan 12, 2023 | 111.65 | 1.40 | 1.27% | 110.25 | 112.00 | 109.91 |
| Jan 11, 2023 | 110.95 | 2.73 | 2.52% | 108.22 | 111.21 | 108.22 |
| Jan 10, 2023 | 110.67 | 1.13 | 1.03% | 109.54 | 111.92 | 109.54 |
| Jan 9, 2023 | 110.25 | -4.52 | -3.94% | 114.77 | 114.77 | 109.83 |
| Jan 6, 2023 | 114.72 | 0.93 | 0.82% | 113.79 | 115.39 | 113.76 |
Merck & Co Inc - USD Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totale inkomsten | 39807 | 40122 | 42294 | 39121 | 41518 | 48704 |
| Inkomsten | 39807 | 40122 | 42294 | 39121 | 41518 | 48704 |
| Kosten van opbrengsten, totaal | 13502 | 12640 | 13065 | 11060 | 11583 | 13241 |
| Brutowinst | 26305 | 27482 | 29229 | 28061 | 29935 | 35463 |
| Totale bedrijfskosten | 34959 | 34101 | 33995 | 31821 | 36545 | 36166 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 9844 | 10028 | 10067 | 9421 | 8908 | 9615 |
| Onderzoek & Ontwikkeling | 6519 | 7495 | 7854 | 8555 | 10102 | 10281 |
| Ongebruikelijke uitgaven (inkomsten) | 5094 | 3938 | 3009 | 2785 | 5952 | 3029 |
| Bedrijfsresultaat | 4848 | 6021 | 8299 | 7300 | 4973 | 12538 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -496 | -116 | 10 | -636 | 421 | 873 |
| Overige, Netto | 307 | 616 | 392 | 507 | 469 | 468 |
| Netto inkomen voor belastingen | 4659 | 6521 | 8701 | 7171 | 5863 | 13879 |
| Netto inkomen na belastingen | 3941 | 5043 | 6482 | 5606 | 4523 | 12358 |
| Minderheidsbelang | -21 | -24 | 27 | 84 | -4 | -13 |
| Netto inkomen voor extra. Posten | 3920 | 5019 | 6509 | 5690 | 4519 | 12345 |
| Netto inkomen | 3920 | 2394 | 6220 | 9843 | 7067 | 13049 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 3920 | 5019 | 6509 | 5690 | 4519 | 12345 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 3920 | 2394 | 6220 | 9843 | 7067 | 13049 |
| Verwaterd Netto Inkomen | 3920 | 2394 | 6220 | 9843 | 7067 | 13049 |
| Verwaterd Gewogen Gemiddelde Aandelen | 2787 | 2748 | 2679 | 2580 | 2541 | 2538 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.40653 | 1.82642 | 2.42964 | 2.20543 | 1.77843 | 4.86407 |
| Dividends per Share - Common Stock Primary Issue | 1.84 | 2.36 | 1.99 | 2.26 | 2.48 | 2.64 |
| Verwaterde Genormaliseerde Winst per Aandeel | 6.11554 | 4.03264 | 4.13343 | 3.96379 | 4.69927 | 6.81007 |
| Totale buitengewone posten | -2625 | -289 | 4153 | 2548 | 704 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 10627 | 11402 | 13154 | 13521 | 15901 |
| Inkomsten | 10627 | 11402 | 13154 | 13521 | 15901 |
| Kosten van opbrengsten, totaal | 2984 | 3029 | 3402 | 3827 | 5334 |
| Brutowinst | 7643 | 8373 | 9752 | 9694 | 10567 |
| Totale bedrijfskosten | 8095 | 9788 | 8338 | 9946 | 10332 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 2185 | 2279 | 2331 | 2820 | 2302 |
| Onderzoek & Ontwikkeling | 2404 | 2611 | 2437 | 3061 | 2569 |
| Ongebruikelijke uitgaven (inkomsten) | 522 | 1869 | 168 | 238 | 127 |
| Bedrijfsresultaat | 2532 | 1614 | 4816 | 3575 | 5569 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 345 | -27 | 448 | 110 | -983 |
| Overige, Netto | 110 | 130 | 2 | 224 | 275 |
| Netto inkomen voor belastingen | 2987 | 1717 | 5266 | 3909 | 4861 |
| Netto inkomen na belastingen | 2749 | 1214 | 4571 | 3824 | 4307 |
| Minderheidsbelang | -4 | -1 | -4 | -4 | 3 |
| Netto inkomen voor extra. Posten | 2745 | 1213 | 4567 | 3820 | 4310 |
| Totale buitengewone posten | 434 | 332 | 0 | -62 | 0 |
| Netto inkomen | 3179 | 1545 | 4567 | 3758 | 4310 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 2745 | 1213 | 4567 | 3820 | 4310 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 3179 | 1545 | 4567 | 3758 | 4310 |
| Verwaterd Netto Inkomen | 3179 | 1545 | 4567 | 3758 | 4310 |
| Verwaterd Gewogen Gemiddelde Aandelen | 2540 | 2540 | 2536 | 2535 | 2537 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.08071 | 0.47756 | 1.80087 | 1.5069 | 1.69886 |
| Dividends per Share - Common Stock Primary Issue | 0.65 | 0.65 | 0.65 | 0.69 | 0.69 |
| Verwaterde Genormaliseerde Winst per Aandeel | 1.44992 | 1.13784 | 2.01068 | 1.9997 | 1.52074 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totaal vlottende activa | 30614 | 24766 | 25875 | 27483 | 27764 | 30266 |
| Geldmiddelen en kortetermijnbeleggingen | 14341 | 8498 | 8864 | 10450 | 8062 | 8096 |
| Geldmiddelen & Equivalenten | 6515 | 6092 | 7965 | 9676 | 8062 | 8096 |
| Korte Termijn Investeringen | 7826 | 2406 | 899 | 774 | 0 | |
| Totale Vorderingen, Netto | 7018 | 6873 | 7071 | 6778 | 7851 | 9230 |
| Accounts Receivable - Trade, Net | 7018 | 6873 | 7071 | 6778 | 7851 | 9230 |
| Total Inventory | 4866 | 5096 | 5440 | 5978 | 6310 | 5953 |
| Other Current Assets, Total | 4389 | 4299 | 4500 | 4277 | 5541 | 6987 |
| Total Assets | 95377 | 87872 | 82637 | 84397 | 91588 | 105694 |
| Property/Plant/Equipment, Total - Net | 12026 | 12439 | 13291 | 16126 | 17986 | 19279 |
| Property/Plant/Equipment, Total - Gross | 27775 | 29041 | 29615 | 33812 | 36968 | 37471 |
| Accumulated Depreciation, Total | -15749 | -16602 | -16324 | -17686 | -18982 | -18192 |
| Goodwill, Net | 18162 | 18284 | 18253 | 19425 | 20238 | 21264 |
| Intangibles, Net | 17305 | 14183 | 11431 | 14196 | 14604 | 22933 |
| Long Term Investments | 12131 | 12892 | 6233 | 1889 | 1371 | 966 |
| Other Long Term Assets, Total | 5139 | 5308 | 7554 | 5278 | 9625 | 10986 |
| Total Current Liabilities | 17204 | 18614 | 22206 | 22220 | 27327 | 23872 |
| Accounts Payable | 2807 | 3102 | 3318 | 3738 | 4594 | 4609 |
| Accrued Expenses | 10170 | 10263 | 10073 | 12453 | 13053 | 13859 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 568 | 3057 | 5308 | 3610 | 6431 | 2412 |
| Other Current Liabilities, Total | 3659 | 2192 | 3507 | 2419 | 3249 | 2992 |
| Total Liabilities | 55289 | 53536 | 55936 | 58490 | 66271 | 67510 |
| Total Long Term Debt | 24274 | 21353 | 19806 | 22736 | 25360 | 30690 |
| Long Term Debt | 24274 | 21353 | 19806 | 22736 | 25360 | 30690 |
| Deferred Income Tax | 5077 | 2219 | 1702 | 1470 | 1015 | 3441 |
| Minority Interest | 220 | 233 | 181 | 94 | 87 | 73 |
| Other Liabilities, Total | 8514 | 11117 | 12041 | 11970 | 12482 | 9434 |
| Total Equity | 40088 | 34336 | 26701 | 25907 | 25317 | 38184 |
| Common Stock | 1788 | 1788 | 1788 | 1788 | 1788 | 1788 |
| Additional Paid-In Capital | 39939 | 39902 | 38808 | 39660 | 39588 | 44238 |
| Retained Earnings (Accumulated Deficit) | 44133 | 41350 | 42579 | 46602 | 47362 | 53696 |
| Treasury Stock - Common | -40546 | -43794 | -50929 | -55950 | -56787 | -57109 |
| Unrealized Gain (Loss) | -3 | -61 | -78 | 18 | 0 | 0 |
| Other Equity, Total | -5223 | -4849 | -5467 | -6211 | -6634 | -4429 |
| Total Liabilities & Shareholders’ Equity | 95377 | 87872 | 82637 | 84397 | 91588 | 105694 |
| Total Common Shares Outstanding | 2748.73 | 2696.61 | 2592.56 | 2539.02 | 2530.23 | 2527.6 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 26909 | 28665 | 31058 | 30266 | 31184 |
| Geldmiddelen en kortetermijnbeleggingen | 6981 | 8575 | 10016 | 8096 | 8928 |
| Geldmiddelen & Equivalenten | 6981 | 8575 | 10016 | 8096 | 8556 |
| Totale Vorderingen, Netto | 8235 | 7843 | 8571 | 9230 | 9828 |
| Accounts Receivable - Trade, Net | 8235 | 7843 | 8571 | 9230 | 9828 |
| Total Inventory | 6402 | 5499 | 5603 | 5953 | 5774 |
| Other Current Assets, Total | 5291 | 6748 | 6868 | 6987 | 6654 |
| Total Assets | 90847 | 90688 | 93494 | 105694 | 106668 |
| Property/Plant/Equipment, Total - Net | 18295 | 18064 | 18565 | 19279 | 19747 |
| Property/Plant/Equipment, Total - Gross | 37027 | 36300 | 36720 | 37471 | 38245 |
| Accumulated Depreciation, Total | -18732 | -18236 | -18155 | -18192 | -18498 |
| Goodwill, Net | 20212 | 18873 | 18862 | 21264 | 21258 |
| Intangibles, Net | 14401 | 13622 | 13384 | 22933 | 23022 |
| Long Term Investments | 1195 | 1105 | 1013 | 966 | 959 |
| Other Long Term Assets, Total | 9835 | 10359 | 10612 | 10986 | 10498 |
| Total Current Liabilities | 26361 | 21906 | 23728 | 23872 | 22316 |
| Accounts Payable | 4034 | 3897 | 3366 | 4609 | 3715 |
| Accrued Expenses | 11911 | 12888 | 14214 | 13859 | 14051 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 7251 | 2488 | 3534 | 2412 | 1208 |
| Other Current Liabilities, Total | 3165 | 2633 | 2614 | 2992 | 3342 |
| Total Liabilities | 63902 | 57394 | 57700 | 67510 | 65785 |
| Total Long Term Debt | 24002 | 24033 | 22907 | 30690 | 30586 |
| Long Term Debt | 24002 | 24033 | 22907 | 30690 | 30586 |
| Deferred Income Tax | 1204 | 1489 | 1527 | 3441 | 3071 |
| Minority Interest | 94 | 94 | 69 | 73 | 70 |
| Other Liabilities, Total | 12241 | 9872 | 9469 | 9434 | 9742 |
| Total Equity | 26945 | 33294 | 35794 | 38184 | 40883 |
| Common Stock | 1788 | 1788 | 1788 | 1788 | 1788 |
| Additional Paid-In Capital | 39613 | 44039 | 44149 | 44238 | 44275 |
| Retained Earnings (Accumulated Deficit) | 48888 | 48777 | 51691 | 53696 | 56252 |
| Treasury Stock - Common | -56722 | -56682 | -57244 | -57109 | -57063 |
| Unrealized Gain (Loss) | 0 | 0 | 0 | 0 | |
| Other Equity, Total | -6622 | -4628 | -4590 | -4429 | -4369 |
| Total Liabilities & Shareholders’ Equity | 90847 | 90688 | 93494 | 105694 | 106668 |
| Total Common Shares Outstanding | 2531.3 | 2532.75 | 2525.32 | 2527.6 | 2528.38 |
| Korte Termijn Investeringen | 372 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | 3941 | 2418 | 6193 | 9777 | 4523 | 12358 |
| Geldmiddelen uit Operationele Activiteiten | 10376 | 6447 | 10922 | 13440 | 10253 | 14109 |
| Geldmiddelen uit Operationele Activiteiten | 5441 | 4637 | 4519 | 3652 | 1669 | 1578 |
| Deferred Taxes | -1521 | -2621 | -509 | -556 | -566 | 187 |
| Niet-Geldelijke Posten | 5116 | 7034 | 2272 | 2634 | 7411 | 2189 |
| Cash Taxes Paid | 1800 | 4900 | 1500 | 4500 | 2700 | 2400 |
| Contant Betaalde Rente | 686 | 723 | 777 | 841 | 822 | 779 |
| Veranderingen in het Operationeel Kapitaal | -2601 | -5021 | -1553 | -2067 | -4601 | -3839 |
| Geldmiddelen uit Investeringsactiviteiten | -3210 | 2679 | 4314 | -2629 | -9443 | -16555 |
| Kapitaaluitgaven | -1614 | -1888 | -2615 | -3473 | -4429 | -4448 |
| Overige Cash Flow investeringsposten, Totaal | -1596 | 4567 | 6929 | 844 | -5014 | -12107 |
| Geldmiddelen uit Financieringsactiviteiten | -9044 | -10006 | -13160 | -8861 | -2832 | 2593 |
| Financiering van Cash Flow Posten | -118 | -195 | -325 | 5 | -436 | 8210 |
| Total Cash Dividends Paid | -5124 | -5167 | -5172 | -5695 | -6215 | -6610 |
| Uitgifte (Aflossing) van aandelen, netto | -2495 | -3515 | -8500 | -4419 | -1192 | -638 |
| Uitgifte (Aflossing) van Schulden, Netto | -1307 | -1129 | 837 | 1248 | 5011 | 1631 |
| Wisselkoerseffecten | -131 | 457 | -205 | 17 | 253 | -133 |
| Nettowijziging in Geldmiddelen | -2009 | -423 | 1871 | 1967 | -1769 | 14 |
| Amortization | 1817 | 1636 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 3186 | 3963 | 8534 | 12358 | 4307 |
| Cash From Operating Activities | 1791 | 4281 | 9078 | 14109 | 4761 |
| Cash From Operating Activities | 396 | 749 | 1148 | 1578 | 421 |
| Amortization | 534 | 871 | 1231 | 1636 | 699 |
| Deferred Taxes | -10 | 29 | 28 | 187 | -338 |
| Non-Cash Items | -211 | 2324 | 1931 | 2189 | 971 |
| Cash Interest Paid | 217 | 363 | 570 | 779 | 211 |
| Changes in Working Capital | -2104 | -3655 | -3794 | -3839 | -1299 |
| Cash From Investing Activities | -738 | -3445 | -4506 | -16555 | -1173 |
| Capital Expenditures | -1134 | -2068 | -3240 | -4448 | -984 |
| Other Investing Cash Flow Items, Total | 396 | -1377 | -1266 | -12107 | -189 |
| Cash From Financing Activities | -2098 | -340 | -2614 | 2593 | -3086 |
| Financing Cash Flow Items | -97 | 8302 | 8243 | 8210 | -103 |
| Total Cash Dividends Paid | -1645 | -3318 | -4967 | -6610 | -1745 |
| Issuance (Retirement) of Stock, Net | 9 | -188 | -754 | -638 | 12 |
| Issuance (Retirement) of Debt, Net | -365 | -5136 | -5136 | 1631 | -1250 |
| Foreign Exchange Effects | -97 | -19 | -65 | -133 | -55 |
| Net Change in Cash | -1142 | 477 | 1893 | 14 | 447 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7946 | 222977541 | 3070577 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4365 | 137837792 | 697229 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.6269 | 117311329 | -480300 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8972 | 48100919 | 2106251 | 2022-09-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.5839 | 40157172 | -566255 | 2022-09-30 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 1.2207 | 30950448 | 1429537 | 2022-09-30 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 1.0307 | 26133153 | -662798 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9382 | 23786901 | -2349731 | 2021-12-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 0.8865 | 22475032 | 1102748 | 2022-09-30 | LOW |
| BofA Global Research (US) | Research Firm | 0.8749 | 22181659 | 303733 | 2022-09-30 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.8648 | 21925926 | 114408 | 2022-09-30 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7772 | 19704612 | -575045 | 2022-09-30 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.7269 | 18429683 | -1379488 | 2022-09-30 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7146 | 18119118 | 1683829 | 2022-09-30 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7136 | 18091768 | -228546 | 2022-09-30 | LOW |
| Managed Account Advisors LLC | Investment Advisor | 0.7031 | 17825870 | 2268172 | 2022-09-30 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.6747 | 17107406 | 366748 | 2022-09-30 | LOW |
| Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.6745 | 17102276 | -39695 | 2022-09-30 | LOW |
| State Farm Insurance Companies | Insurance Company | 0.5613 | 14231200 | 0 | 2022-09-30 | LOW |
| Invesco Advisers, Inc. | Investment Advisor | 0.5587 | 14166387 | -614838 | 2022-09-30 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group +485000+
Handelaren
65000+
Actieve klanten per maand
$48000000+
Maandelijks beleggingsvolume
$28000000+
Probeer het nu Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Handelscommissie
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Hefboom
20:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Merck - USD Company profile
Over Merck & Co Inc - USD
Merck & Co, Inc. is een wereldwijd bedrijf in de gezondheidszorg. Het bedrijf biedt gezondheidsoplossingen via zijn geneesmiddelen op recept, vaccins, biologische therapieën en gezondheidsproducten voor dieren. Het bedrijf opereert via twee segmenten: Farmaceutica en Diergezondheid. Het farmaceutische segment van de onderneming omvat farmaceutische producten voor de menselijke gezondheid en vaccins. De farmaceutische producten voor de menselijke gezondheid bestaan uit therapeutische en preventieve middelen, die meestal op voorschrift worden verkocht, voor de behandeling van menselijke aandoeningen. De onderneming verkoopt deze farmaceutische producten voor de menselijke gezondheid hoofdzakelijk aan groothandelaars en kleinhandelaars in geneesmiddelen, ziekenhuizen, overheidsinstanties en zorgverstrekkers zoals organisaties voor gezondheidszorg. Het segment diergezondheid ontwikkelt, produceert en verkoopt een gamma van veterinaire farmaceutische producten en vaccins, alsook oplossingen en diensten op het vlak van gezondheidsbeheer, voor de preventie, behandeling en controle van ziekten bij alle veesoorten en gezelschapsdieren.
| Industry: | Pharmaceuticals (NEC) |
2000 Galloping Hill Road
KENILWORTH
NEW JERSEY 07033
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 485.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen